Maternal cytomegalovirus serology results by geographic region in a large multicenter United States study
Document Type
Journal Article
Publication Date
4-18-2026
Journal
The Journal of infectious diseases
DOI
10.1093/infdis/jiag224
Keywords
adverse pregnancy outcomes; cytomegalovirus hyperimmune globulin
Abstract
Congenital cytomegalovirus (CMV) infection, due to both nonprimary and primary maternal infection, affects nearly 1% of neonates. In conducting a randomized trial of hyperimmune globulin for prevention of congenital CMV infection, we screened over 200,000 pregnancies across the United States for evidence of prior or primary CMV infection and evaluated their geographic variation. Although the majority were seropositive, seroprevalence and primary infection risk varied significantly by geographic region, with seroprevalence the highest (88%) and primary infection (0.2%) the lowest in the Southwest. This variation in seroprevalence by geography may inform planning of public health measures to decrease congenital CMV.
APA Citation
Hughes, Brenna L.; MacPherson, Cora; Rouse, Dwight J.; Saade, George R.; Dinsmoor, Mara J.; Reddy, Uma M.; Pass, Robert; Allard, Donna; Mallett, Gail; Clifton, Rebecca G.; Gyamfi-Bannerman, Cynthia; Varner, Michael W.; Goodnight, William H.; Tita, Alan T.; Costantine, Maged M.; Swamy, Geeta K.; Heyborne, Kent D.; Chien, Edward K.; Chauhan, Suneet P.; El-Sayed, Yasser Y.; Casey, Brian M.; Parry, Samuel; Simhan, Hyagriv N.; Napolitano, Peter G.; and Macones, George A., "Maternal cytomegalovirus serology results by geographic region in a large multicenter United States study" (2026). GW Authored Works. Paper 9036.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/9036
Department
Epidemiology